Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

An integrated multi-omics analysis identifies clinically relevant molecular subtypes of non-muscle-invasive bladder cancer

Sia Viborg Lindskrog, Frederik F. Prip, Philippe Lamy, Ann Taber, Clarice S. Groeneveld, Karin Birkenkamp-Demtröder, Jørgen Bjerggaard Jensen, Trine Strandgaard, Iver Nordentoft, Emil Christensen, Mateo Sokac, Nicolai J. Birkbak, Lasse Maretty, Gregers G. Hermann, Astrid C. Petersen, Veronika Weyerer, Marc-Oliver Grimm, Marcus Horstmann, Gottfrid Sjödahl, Mattias Höglund, Torben Steiniche, Karin Mogensen, Aurélien de Reyniès, Roman Nawroth, Brian Jordan, Xiaoqi Lin, Dejan Dragicevic, Douglas G. Ward, Anshita Goel, Carolyn D. Hurst, Jay D. Raman, Joshua I. Warrick, Ulrika Segersten, Danijel Sikic, Kim E.M. van Kessel, Tobias Maurer, Joshua J. Meeks, David J. DeGraff, Richard T. Bryan, Margaret A. Knowles, Tatjana Simic, Arndt Hartmann, Ellen C. Zwarthoff, Per-Uno Malmström, Núria Malats, Francisco X. Real, View ORCID ProfileLars Dyrskjøt
doi: https://doi.org/10.1101/2020.06.19.20054809
Sia Viborg Lindskrog
1Department of Molecular Medicine, Aarhus University Hospital, 8200 Aarhus N, Denmark
2Department of Clinical Medicine, Aarhus University, 8000 Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frederik F. Prip
1Department of Molecular Medicine, Aarhus University Hospital, 8200 Aarhus N, Denmark
2Department of Clinical Medicine, Aarhus University, 8000 Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philippe Lamy
1Department of Molecular Medicine, Aarhus University Hospital, 8200 Aarhus N, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ann Taber
1Department of Molecular Medicine, Aarhus University Hospital, 8200 Aarhus N, Denmark
2Department of Clinical Medicine, Aarhus University, 8000 Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clarice S. Groeneveld
3Cartes d’Identité des Tumeurs (CIT) Program, Ligue Nationale Contre le Cancer, Paris, 14 rue Corvisart 75013 Paris, France and Oncologie Moleculaire, UMR144, Institut Curie, 12 rue Lhomond, 75005 Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karin Birkenkamp-Demtröder
1Department of Molecular Medicine, Aarhus University Hospital, 8200 Aarhus N, Denmark
2Department of Clinical Medicine, Aarhus University, 8000 Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jørgen Bjerggaard Jensen
2Department of Clinical Medicine, Aarhus University, 8000 Aarhus, Denmark
4Department of Urology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Trine Strandgaard
1Department of Molecular Medicine, Aarhus University Hospital, 8200 Aarhus N, Denmark
2Department of Clinical Medicine, Aarhus University, 8000 Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Iver Nordentoft
1Department of Molecular Medicine, Aarhus University Hospital, 8200 Aarhus N, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emil Christensen
1Department of Molecular Medicine, Aarhus University Hospital, 8200 Aarhus N, Denmark
2Department of Clinical Medicine, Aarhus University, 8000 Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mateo Sokac
1Department of Molecular Medicine, Aarhus University Hospital, 8200 Aarhus N, Denmark
2Department of Clinical Medicine, Aarhus University, 8000 Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolai J. Birkbak
1Department of Molecular Medicine, Aarhus University Hospital, 8200 Aarhus N, Denmark
2Department of Clinical Medicine, Aarhus University, 8000 Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lasse Maretty
1Department of Molecular Medicine, Aarhus University Hospital, 8200 Aarhus N, Denmark
2Department of Clinical Medicine, Aarhus University, 8000 Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gregers G. Hermann
5Department of Urology, Herlev hospital, Copenhagen University, Borgmester Ib Juuls vej 23a, 2730 Herlev, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Astrid C. Petersen
6Department of Pathology, Aalborg University Hospital, Ladegaardsgade 3, 9000 Aalborg, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Veronika Weyerer
7Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Krankenhausstrasse 8-10, 91054 Erlangen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc-Oliver Grimm
8Department of Urology, Jena University Hospital, Am Klinikum 1, 07747 Jena, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcus Horstmann
8Department of Urology, Jena University Hospital, Am Klinikum 1, 07747 Jena, Germany
9Department of Urology, Malteser Hospital St. Josephshospital, Krefeld Uerdingen, Kurfürstenstr. 69, 47829 Krefeld, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gottfrid Sjödahl
10Division of Urological Research, Department of Translational Medicine, Lund University, Skåne University Hospital, Malmö, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mattias Höglund
11Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Torben Steiniche
12Department of Pathology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karin Mogensen
5Department of Urology, Herlev hospital, Copenhagen University, Borgmester Ib Juuls vej 23a, 2730 Herlev, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aurélien de Reyniès
13Cartes d’Identité des Tumeurs (CIT) Program, Ligue Nationale Contre le Cancer, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roman Nawroth
14Department of Urology, Technical University of Munich, Klinikum rechts der Isar, Ismaninger Str. 22, 81675 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian Jordan
15Northwestern University School of Medicine, Chicago, Illinois, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaoqi Lin
15Northwestern University School of Medicine, Chicago, Illinois, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dejan Dragicevic
16Clinic of Urology, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Resavska 51, 11000 Belgrade, Serbia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Douglas G. Ward
17Institute of Cancer and Genomic Sciences, College of Medicine and Dental Sciences, University of Birmingham, Birmingham B15 2TT, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anshita Goel
17Institute of Cancer and Genomic Sciences, College of Medicine and Dental Sciences, University of Birmingham, Birmingham B15 2TT, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carolyn D. Hurst
18Leeds Institute of Medical Research at St James’s, University of Leeds, LS9 7TF, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jay D. Raman
19Department of Surgery, Division of Urology, Pennsylvania State University, 500 University Drive, Hershey Pennsylvania, 17033, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joshua I. Warrick
20Department of Pathology and Laboratory Medicine, Department of Surgery Division of Urology, Department of Biochemistry and Molecular Biology, Pennsylvania State University, 500 University Drive, Hershey Pennsylvania, 17033, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ulrika Segersten
21Department of Surgical Sciences, Uppsala University, Uppsala 751 85, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Danijel Sikic
22Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Krankenhausstrasse 12, 91054 Erlangen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kim E.M. van Kessel
23Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Na-1710, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tobias Maurer
14Department of Urology, Technical University of Munich, Klinikum rechts der Isar, Ismaninger Str. 22, 81675 Munich, Germany
24Department of Urology and Martini-Clinic, University Medical Center Hamburg-Eppendorf, Martini-Str. 52, 20246 Hamburg, German
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joshua J. Meeks
15Northwestern University School of Medicine, Chicago, Illinois, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David J. DeGraff
20Department of Pathology and Laboratory Medicine, Department of Surgery Division of Urology, Department of Biochemistry and Molecular Biology, Pennsylvania State University, 500 University Drive, Hershey Pennsylvania, 17033, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard T. Bryan
17Institute of Cancer and Genomic Sciences, College of Medicine and Dental Sciences, University of Birmingham, Birmingham B15 2TT, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margaret A. Knowles
18Leeds Institute of Medical Research at St James’s, University of Leeds, LS9 7TF, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tatjana Simic
25Institute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, Pasterova 2, 11000 Belgrade, Serbia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arndt Hartmann
7Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Krankenhausstrasse 8-10, 91054 Erlangen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ellen C. Zwarthoff
23Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Na-1710, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Per-Uno Malmström
21Department of Surgical Sciences, Uppsala University, Uppsala 751 85, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Núria Malats
26Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), C/Melchor Fernandez Almagro 3, 28029-Madrid, and CIBERONC, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francisco X. Real
27Epithelial Carcinogenesis Group, Spanish National Cancer Research Center (CNIO), C/Melchor Fernandez Almagro 3, 28029-Madrid; Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, 08003-Barcelona; and CIBERONC, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lars Dyrskjøt
1Department of Molecular Medicine, Aarhus University Hospital, 8200 Aarhus N, Denmark
2Department of Clinical Medicine, Aarhus University, 8000 Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lars Dyrskjøt
  • For correspondence: lars{at}clin.au.dk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

The molecular landscape in non-muscle-invasive bladder cancer (NMIBC) is characterized by large biological heterogeneity with variable clinical outcomes. Here, we performed a large integrative multi-omics analysis of patients diagnosed with NMIBC (n=834). Transcriptomic analysis identified four classes (1, 2a, 2b and 3) reflecting tumor biology and disease aggressiveness. Both transcriptome-based subtyping and the level of chromosomal instability provided independent prognostic value beyond established prognostic clinicopathological parameters. High chromosomal instability, p53-pathway disruption and APOBEC-related mutations were significantly associated with transcriptomic class 2a and poor outcome. RNA-derived immune cell infiltration was associated with chromosomally unstable tumors and enriched in class 2b. Spatial proteomics analysis confirmed the higher infiltration of class 2b tumors and demonstrated an association between higher immune cell infiltration and lower recurrence rates. Finally, a single-sample classification tool was built and the independent prognostic value of the transcriptomic classes was documented in 1306 validation samples. The classifier provides a framework for novel biomarker discovery and for optimizing treatment and surveillance in next-generation clinical trials.

Competing Interest Statement

L.D. has sponsored research agreements with C2i-genomics, Natera, AstraZeneca and Ferring, and has an advisory/consulting role at Ferring. J.B.J. has sponsored research agreements with Medac, Photocure ASA, Cephaid, Nucleix, Astellas and Ferring, and has an advisory board role at Olympus Europe, Cephaid and Ferring. J.D.R. is involved in a sponsored scientific study or trial with Pacific Edge Biotechnologies, MDxHealth and Urogen Pharma, is a consultant for Urogen Pharma, and has an investment interest in American Kidney Stone Management. J. J. M. is a consultant for Ferring, AstraZeneca, Janssen and participated in advisory boards for Foundation Medicine and Nucleix.

Funding Statement

Funding: SVL, FFP, and LD are supported by the following funding sources: Aarhus University, The Danish Cancer Biobank, The Health Research Foundation of Central Denmark Region, The Danish Cancer Society. NM and FXR are supported by Fondo de Investigaciones Sanitarias (FIS), Instituto de Salud Carlos III, Spain (#PI18/01347), Asociacion Espanola Contra el Cancer (AECC, # GB28012014). DJD is supported by the following funding sources: RSG 17 233 01 TBE from the American Cancer Society, the W.W. Smith Charitable Trust, the Pennsylvania Department of Health via Tobacco CURE Funds, the Ken and Bonnie Shockey Fund for Urologic Research and the Bladder Cancer Support Group at Penn State Health. JIW is supported by the Laurence M. Demers Career Development Professorship in Pathology and Medicine, Pennsylvania State University. JDR is supported by the Ken and Bonnie Shockey Fund for Urologic Research at Penn State Health. JM is funded by a SEED Award from the HOPE Foundation, the Department of Defense (W81XWH-18-0257), and the VHA (BX003692-01). Ethichal review boards: The study was approved by the Central Denmark Region Committees on Biomedical Research Ethics (#1994/2920; Skejby, Aalborg, Frederiksberg); the Danish National Committee on Health Research Ethics (#1906019), the ethics committee of the University Hospital Erlangen (#3755); the ethics committee of the Technical University of Munich (#2792/10); Medical Ethics Committee of Erasmus MC (MEC#168.922/1998/55; Rotterdam); the Uppsala Region Committee on Biomedical Research Ethics (#2008/252); the Ethical Committee of Faculty of Medicine, University of Belgrade (#440/VI-7); the Ethics Committee (CEIC) of Institut Municipal dAssistencia Sanitaria/Hospital del Mar (2008/3296/I); the ethics committee of the University Hospital Jena (#4774-4/16).

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Normalized RNA read counts (accession# to be included, submission in progress) and SNP microarray data (accession# to be included, submission in progress) are deposited at the European Bioinformatics Institute (EMBL-EBI) Array Express. Raw sequencing data is deposited at The European Genome-phenome Archive (EGA) under accession numbers EGAS00001001236 and EGASxx (submission in progress). There are restrictions to the availability of raw sequencing data deposited at EGA due to Danish legislation regarding sharing and processing of sensitive personal data. Data can be shared if the new research purposes proposed by the data importers are approved by the National Committee on Health Research Ethics in Denmark. Furthermore, data processor agreements and contracts need to be signed to fulfil European GDPR data sharing rules. The lead contact will accommodate reasonable requests. Processed (non-sensitive) data will be shared upon request without restrictions.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted June 22, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
An integrated multi-omics analysis identifies clinically relevant molecular subtypes of non-muscle-invasive bladder cancer
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
An integrated multi-omics analysis identifies clinically relevant molecular subtypes of non-muscle-invasive bladder cancer
Sia Viborg Lindskrog, Frederik F. Prip, Philippe Lamy, Ann Taber, Clarice S. Groeneveld, Karin Birkenkamp-Demtröder, Jørgen Bjerggaard Jensen, Trine Strandgaard, Iver Nordentoft, Emil Christensen, Mateo Sokac, Nicolai J. Birkbak, Lasse Maretty, Gregers G. Hermann, Astrid C. Petersen, Veronika Weyerer, Marc-Oliver Grimm, Marcus Horstmann, Gottfrid Sjödahl, Mattias Höglund, Torben Steiniche, Karin Mogensen, Aurélien de Reyniès, Roman Nawroth, Brian Jordan, Xiaoqi Lin, Dejan Dragicevic, Douglas G. Ward, Anshita Goel, Carolyn D. Hurst, Jay D. Raman, Joshua I. Warrick, Ulrika Segersten, Danijel Sikic, Kim E.M. van Kessel, Tobias Maurer, Joshua J. Meeks, David J. DeGraff, Richard T. Bryan, Margaret A. Knowles, Tatjana Simic, Arndt Hartmann, Ellen C. Zwarthoff, Per-Uno Malmström, Núria Malats, Francisco X. Real, Lars Dyrskjøt
medRxiv 2020.06.19.20054809; doi: https://doi.org/10.1101/2020.06.19.20054809
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
An integrated multi-omics analysis identifies clinically relevant molecular subtypes of non-muscle-invasive bladder cancer
Sia Viborg Lindskrog, Frederik F. Prip, Philippe Lamy, Ann Taber, Clarice S. Groeneveld, Karin Birkenkamp-Demtröder, Jørgen Bjerggaard Jensen, Trine Strandgaard, Iver Nordentoft, Emil Christensen, Mateo Sokac, Nicolai J. Birkbak, Lasse Maretty, Gregers G. Hermann, Astrid C. Petersen, Veronika Weyerer, Marc-Oliver Grimm, Marcus Horstmann, Gottfrid Sjödahl, Mattias Höglund, Torben Steiniche, Karin Mogensen, Aurélien de Reyniès, Roman Nawroth, Brian Jordan, Xiaoqi Lin, Dejan Dragicevic, Douglas G. Ward, Anshita Goel, Carolyn D. Hurst, Jay D. Raman, Joshua I. Warrick, Ulrika Segersten, Danijel Sikic, Kim E.M. van Kessel, Tobias Maurer, Joshua J. Meeks, David J. DeGraff, Richard T. Bryan, Margaret A. Knowles, Tatjana Simic, Arndt Hartmann, Ellen C. Zwarthoff, Per-Uno Malmström, Núria Malats, Francisco X. Real, Lars Dyrskjøt
medRxiv 2020.06.19.20054809; doi: https://doi.org/10.1101/2020.06.19.20054809

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Urology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)